Scanning the human genome and the horizon: the potential and pitfalls of pharmacogenetics and stratified medicine

Editorial

. 2015 Jun;65(635):284-5.

doi: 10.3399/bjgp15X685153.

Affiliations

¹ Senior Lecturer in Molecular Medicine, Norwich Medical School, University of East Anglia, Norwich.
² Medical Sociologist and Senior Lecturer, Norwich Medical School, University of East Anglia, Norwich.
³ Professor of Medicine and Pharmacology, Norwich Medical School, University of East Anglia, Norwich.

Editorial

Barbara A Jennings et al. Br J Gen Pract. 2015 Jun.

. 2015 Jun;65(635):284-5.

doi: 10.3399/bjgp15X685153.

¹ Senior Lecturer in Molecular Medicine, Norwich Medical School, University of East Anglia, Norwich.
² Medical Sociologist and Senior Lecturer, Norwich Medical School, University of East Anglia, Norwich.
³ Professor of Medicine and Pharmacology, Norwich Medical School, University of East Anglia, Norwich.

No abstract available

References

1. Lander ES. Initial impact of the sequencing of the human genome. Nature. 2011;470(7333):187–197. - PubMed
1. Hayden EC. Technology: the $1,000 genome. Nature. 2014;507(7492):294–295. - PubMed
1. Hindorff LA, MacArthur J, European Bioinformatics Institute. Morales J, European Bioinformatics Institute et al. A catalog of published genome-wide association studies. www.genome.gov/gwastudies (accessed 29 Apr 2015)
1. Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol. 2012;29(6):613–624. - PubMed
1. Schully SD, Benedicto CB, Khoury MJ. How can we stimulate translational research in cancer genomics beyond bench to bedside? Genet Med. 2012;14(1):169–170. - PubMed